長期作用の注射用サスペンションの開発に関する洞察

Nilesh Malavia¹, Diane J Burgess¹

¹University of Connecticut, Department of Pharmaceutical Sciences, Storrs, CT 06269, USA.

Journal of controlled release : official journal of the Controlled Release Society

|February 14, 2026

まとめ

長期作用注射用サスペンション (LAI) は,慢性疾患に対する持続的な薬物投与を提供します. これらの複雑な製剤の開発は困難ですが,特徴づけとモデリングの進歩は,改善された治療法の道を開いています.

科学分野:

医薬品科学医薬品科学とは
薬物の配送システムです.
バイオ医薬品バイオ医薬品

背景:

長期作用注射用サスペンション (LAI) は,慢性疾患の管理に有用であり,アデバーンスを改善し,投与頻度を減らすことができます.
利点にもかかわらず,LAIサスペンションの開発は,複雑な放出メカニズムを理解し,重要な品質属性 (CQA) を定義し,堅固なin vitro-in vivo相関関係 (IVIVC) を確立する上で課題に直面しています.

研究の目的:

LAIのサスペンション開発の現在の状況の包括的な見直しを提供するために.
最近の進歩を強調し,LAIのサスペンション製剤と規制当局の承認における課題と将来の研究方向性を特定します.

主な方法:

市場動向,治療用途,規制ガイドライン,製造プロセス,および主要な配方CQAの詳細な分析.
物理化学的特徴化,インビトロ放出試験,IVIVC,および生理学ベースの薬理学動力学 (PBPK) モデリングにおける進歩のレビュー.
薬剤の放出に対する粒子の特性とデポ形成の影響と,新しいインビトロ方法の強調.

主要な成果:

LAIのサスペンションは,重要な医薬品の機会を提示しますが,複雑な放出と定義されていないCQAsのために開発のハードルに直面しています.
最近の進歩には,強化された特徴付け技術,新しいin vitro放出アッセイ,IVIVCおよびPBPKモデルの開発が含まれています.
粒子の大きさ,集積,およびデポ形成は,薬物放出運動に影響を与える重要な要因です.

結論:

規制や技術的な障壁を克服するには,生物学的 Release 方法やメカニズムモデリングを含む革新的なアプローチが必要です.
薬剤の放出を理解し予測する分野での進歩は,LAIサスペンションの開発と承認の成功に不可欠です.
このレビューは,科学者や規制当局がLAIサスペンション技術の分野を進めるための洞察を提供します.

キーワード:

貯蔵庫の形成を図った.インビトロ・インビボ相関 (IVIVC)長期作用の注射用サスペンション (LAI)薬物の放出に関する新しい方法粒子の集積というものです.

さらに関連する動画

10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.8K

07:20

Cell Labeling and Injection in Developing Embryonic Mouse Hearts

Published on: April 17, 2014

14.6K

関連する概念動画

02:11

Forces Acting on Chromosomes

4.0K

During mitosis, chromosome movements occur through the interplay of multiple piconewton level forces. In prometaphase, these forces help in chromosome assembly or congression at the equatorial plane, eventually leading to their alignment at the metaphase plate. The forces acting on the chromosomes are space and time-dependent; therefore, they vary with the position of the chromosomes as the cell progresses through mitosis.
Microtubules and motor proteins exert two types of forces on...

4.0K

01:17

Colloids and Suspensions

3.6K

Children at play often make suspensions such as mixtures of mud and water, flour and water, or a suspension of solid pigments in water known as tempera paint. These suspensions are heterogeneous mixtures composed of relatively large particles visible to the naked eye or seen with a magnifying glass. They are cloudy, and the suspended particles settle out after mixing. The suspended particles in a suspension settle out after some time of mixing. The separation of particles from a suspension is...

3.6K

01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

1.9K

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...

1.9K

01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.1K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

2.1K

01:28

Drugs Acting on Autonomic Ganglia: Blockers

1.7K

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:

1.7K

01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

1.8K

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...